[Prolonged response with paclitaxel after immunotherapy by pembrolizumab in lung cancer]. [electronic resource]
- Revue de pneumologie clinique Oct 2016
- 300-304 p. digital
Publication Type: Case Reports; Journal Article
1776-2561
10.1016/j.pneumo.2016.05.004 doi
Aged Antibodies, Monoclonal, Humanized--therapeutic use Carcinoma, Non-Small-Cell Lung--pathology Chemotherapy, Adjuvant Combined Modality Therapy Female Humans Immunotherapy Lung Neoplasms--pathology Paclitaxel--therapeutic use Time Factors Treatment Outcome